{"id":"prophylactic-heparin","safety":{"commonSideEffects":[{"rate":"1-10","effect":"Bleeding"},{"rate":"0.1-3","effect":"Heparin-induced thrombocytopenia (HIT)"},{"rate":"0.1-1","effect":"Thrombosis"},{"rate":"1-5","effect":"Injection site reactions"},{"rate":null,"effect":"Osteoporosis (with prolonged use)"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Heparin is an anticoagulant that potentiates antithrombin III, a natural inhibitor of several blood coagulation factors (particularly factors IIa and Xa). By accelerating the inactivation of these clotting factors, heparin reduces the formation of fibrin clots and prevents thromboembolism. When used prophylactically, it is administered at lower doses to prevent clot formation in high-risk patients without causing therapeutic anticoagulation.","oneSentence":"Prophylactic heparin inhibits blood clotting by enhancing the activity of antithrombin III, preventing thrombus formation.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T00:02:56.807Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Prophylaxis of venous thromboembolism in surgical patients"},{"name":"Prophylaxis of thromboembolism in medical patients at risk"},{"name":"Prevention of clotting in extracorporeal circulation"}]},"trialDetails":[{"nctId":"NCT06753786","phase":"NA","title":"Timing of Venous Thromboembolism Prophylaxis in Patients With Hypertensive Intracerebral Hemorrhage","status":"RECRUITING","sponsor":"Pirogov Russian National Research Medical University","startDate":"2024-10-21","conditions":"Venous Thromboembolism, Pulmonary Embolism, Intracerebral Hemorrhage","enrollment":200},{"nctId":"NCT07299695","phase":"PHASE3","title":"Intravenous Immunoglobulin for the Treatment of Acute Exacerbations of Idiopathic Pulmonary Fibrosis","status":"RECRUITING","sponsor":"Argyrios Tzouvelekis","startDate":"2026-01-25","conditions":"Idiopathic Pulmonary Fibrosis, Acute Exacerbation of Idiopathic Pulmonary Fibrosis","enrollment":196},{"nctId":"NCT05498428","phase":"PHASE2","title":"A Study of Amivantamab in Participants With Advanced or Metastatic Solid Tumors Including Epidermal Growth Factor Receptor (EGFR)-Mutated Non-Small Cell Lung Cancer","status":"RECRUITING","sponsor":"Janssen Research & Development, LLC","startDate":"2022-11-11","conditions":"Carcinoma, Non-small-Cell Lung","enrollment":520},{"nctId":"NCT07388056","phase":"","title":"Efficacy and Safety of Extended Anticoagulant Therapy in Cancer Associated Thrombosis in Thai Population","status":"COMPLETED","sponsor":"Thammasat University","startDate":"2012-01-01","conditions":"Cancer-associated Thrombosis","enrollment":169},{"nctId":"NCT06243510","phase":"NA","title":"Comparison of Apixaban Versus Enoxaparin","status":"ENROLLING_BY_INVITATION","sponsor":"Abramson Cancer Center at Penn Medicine","startDate":"2023-11-24","conditions":"Bladder Cancer","enrollment":90},{"nctId":"NCT06381661","phase":"PHASE2","title":"Adaptive Platform Trial for Personnalisation of Sepsis Treatment in Children and Adults: a Multi-national, Treatable Traits-guided, Adaptive, Exploratory, Bayesian Basket Trial","status":"NOT_YET_RECRUITING","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2026-05-01","conditions":"Sepsis","enrollment":2000},{"nctId":"NCT07365644","phase":"","title":"Prophylactic ANTicoagulation With HEparine in Critically Ill Patients With Renal Impairment","status":"NOT_YET_RECRUITING","sponsor":"Centre Hospitalier le Mans","startDate":"2026-01-01","conditions":"Prophylactic Anticoagulation","enrollment":1111},{"nctId":"NCT04273607","phase":"PHASE2, PHASE3","title":"Anticoagulation-free VV ECMO for Acute Respiratory Failure","status":"RECRUITING","sponsor":"Damian Ratano","startDate":"2022-09-01","conditions":"Extracorporeal Membrane Oxygenation Complication","enrollment":40},{"nctId":"NCT07342127","phase":"","title":"Evaluation of a Preventive Therapeutic Strategy for Postpartum Venous Thromboembolism in Women With Genetic Risk Factor","status":"NOT_YET_RECRUITING","sponsor":"Hospices Civils de Lyon","startDate":"2026-02-01","conditions":"Factor V Leiden Heterozygous Mutation, Factor II Heterozygous Mutation, Pregnancy","enrollment":100},{"nctId":"NCT05089227","phase":"PHASE2","title":"Efficacy of Prolonged Anticoagulation for Primary Prevention of Venous Thromboembolic Disease in Autoimmune Hemolytic Anemia: a Prospective, Phase II, Randomized, Multicenter Study","status":"RECRUITING","sponsor":"Centre Hospitalier Universitaire Dijon","startDate":"2022-02-03","conditions":"Prolonged Anticoagulation, Venous Thromboembolic Disease, Autoimmune Hemolytic Anemia","enrollment":72},{"nctId":"NCT06195540","phase":"PHASE3","title":"RIVAroxaban Versus Low-molecular Weight Heparin in Patients With Lower Limb Trauma Requiring Brace or CASTing","status":"RECRUITING","sponsor":"University Hospital, Angers","startDate":"2024-07-19","conditions":"Venous Thromboembolism, Deep Vein Thrombosis, Pulmonary Embolism","enrollment":1424},{"nctId":"NCT06204549","phase":"NA","title":"Impact of Assessment and Management of Comorbidities in Internal Medicine on Cardiovascular Risk","status":"RECRUITING","sponsor":"University Hospital, Montpellier","startDate":"2024-05-21","conditions":"Adverse Cardiac Event, Major Adverse Cardiac Events","enrollment":70},{"nctId":"NCT05625932","phase":"PHASE3","title":"TINzaparin Prophylaxis in Patients With Metastatic Colorectal Cancer","status":"COMPLETED","sponsor":"Galician Research Group on Digestive Tumors","startDate":"2023-03-02","conditions":"Colorectal Cancer Metastatic, Thromboembolism","enrollment":232},{"nctId":"NCT07127718","phase":"PHASE2","title":"Preventive Strategies for Early and Late Complications of Leptospirosis","status":"RECRUITING","sponsor":"National Kidney and Transplant Institute, Philippines","startDate":"2024-04-12","conditions":"Leptospirosis","enrollment":678},{"nctId":"NCT06484231","phase":"","title":"Evaluation of the Effectiveness of Prophylactic LMWH by Thromboelastography","status":"COMPLETED","sponsor":"Ege University","startDate":"2023-07-24","conditions":"Malignancy","enrollment":25},{"nctId":"NCT04924322","phase":"PHASE2, PHASE3","title":"Catheter-Related Early Thromboprophylaxis With Enoxaparin Studies","status":"RECRUITING","sponsor":"Yale University","startDate":"2022-05-11","conditions":"Deep Venous Thrombosis","enrollment":258},{"nctId":"NCT06845423","phase":"PHASE4","title":"Prevention of Postpartum Venous Thromboembolism in Women at Intermediate Risk","status":"RECRUITING","sponsor":"University Hospital, Brest","startDate":"2025-05-16","conditions":"Venous Thromboembolism (VTE), Post Partum Women","enrollment":2400},{"nctId":"NCT05735639","phase":"PHASE4","title":"THRomboprophylaxis in Individuals Undergoing Superficial endoVEnous Treatment (THRIVE)","status":"RECRUITING","sponsor":"Imperial College London","startDate":"2024-01-22","conditions":"Venous Thromboembolism, Varicose Veins","enrollment":6660},{"nctId":"NCT05058924","phase":"NA","title":"Low Molecular Weight hEparin vs. Aspirin Post-partum","status":"COMPLETED","sponsor":"Mount Sinai Hospital, Canada","startDate":"2021-08-29","conditions":"Venous Thromboembolism","enrollment":30},{"nctId":"NCT04507178","phase":"PHASE2","title":"Improving Outcome in Subarachnoid Hemorrhage wIth Nadroparine","status":"RECRUITING","sponsor":"Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)","startDate":"2022-02-02","conditions":"Aneurysmal Subarachnoid Hemorrhage, Delayed Cerebral Ischemia","enrollment":100},{"nctId":"NCT06795698","phase":"PHASE2","title":"The Effect of Prophylactic Anticoagulation on Major Bleeding Events in Hospitalized Chronic Kidney Disease and Lower Limb Fracture Patients.","status":"COMPLETED","sponsor":"Hospital Civil de Guadalajara","startDate":"2019-03-01","conditions":"Fractures, Bone, CKD Stage 4, CKD Stage 3","enrollment":61},{"nctId":"NCT04710732","phase":"PHASE4","title":"Individual Dose Adjustment of Low-molecular-weight-heparin by Thromodynamics Test.","status":"TERMINATED","sponsor":"Pirogov Russian National Research Medical University","startDate":"2021-03-01","conditions":"Venous Thromboembolism","enrollment":9},{"nctId":"NCT04505774","phase":"PHASE4","title":"Accelerating COVID-19 Therapeutic Interventions and Vaccines 4 ACUTE","status":"COMPLETED","sponsor":"Matthew Neal MD","startDate":"2020-09-04","conditions":"Covid19","enrollment":3591},{"nctId":"NCT04367831","phase":"PHASE4","title":"Intermediate or Prophylactic-Dose Anticoagulation for Venous or Arterial Thromboembolism in Severe COVID-19","status":"COMPLETED","sponsor":"Columbia University","startDate":"2020-05-02","conditions":"COVID-19, Venous Thromboses, Arterial Thrombosis","enrollment":94},{"nctId":"NCT03559114","phase":"PHASE3","title":"PROphylaxis for Venous ThromboEmbolism in Severe Traumatic Brain Injury (PROTEST)","status":"RECRUITING","sponsor":"Sunnybrook Health Sciences Centre","startDate":"2018-07-19","conditions":"Traumatic Brain Injury","enrollment":1100},{"nctId":"NCT06583330","phase":"NA","title":"A Multicenter, Open-Label, Non-Inferiority Randomized Controlled Trial of Postoperative VTE Prevention in Chinese Patients After Colorectal Cancer Surgery","status":"NOT_YET_RECRUITING","sponsor":"Beijing Friendship Hospital","startDate":"2024-10","conditions":"Colorectal Surgery, VTE (Venous Thromboembolism)","enrollment":1448},{"nctId":"NCT06259149","phase":"","title":"A Study of Initiation Timing of VTE Prevention After Colorectal Cancer Surgery","status":"RECRUITING","sponsor":"RenJi Hospital","startDate":"2024-02-01","conditions":"Colorectal Cancer","enrollment":914},{"nctId":"NCT06513481","phase":"","title":"A Study of Enhancing Drug Prophylaxis of Venous Thromboembolism in Chinese Colorectal Cancer Surgery","status":"NOT_YET_RECRUITING","sponsor":"RenJi Hospital","startDate":"2024-07-16","conditions":"Colorectal Cancer","enrollment":914},{"nctId":"NCT05540834","phase":"PHASE2","title":"Viscoelastic Testing Guided Tissue Plasminogen Activator Treatment in Acute Respiratory Failure","status":"RECRUITING","sponsor":"South West Sydney Local Health District","startDate":"2022-05-18","conditions":"Acute Respiratory Failure, Hypercoagulability, Fibrinolysis Shutdown","enrollment":70},{"nctId":"NCT03659708","phase":"NA","title":"Pregnancy and Risk of Venous Thromboembolism","status":"RECRUITING","sponsor":"Hospices Civils de Lyon","startDate":"2021-01-22","conditions":"Thromboembolism, Pregnancy","enrollment":600},{"nctId":"NCT02580773","phase":"PHASE3","title":"Therapeutic Anticoagulation Strategy for Acute Chest Syndrome","status":"COMPLETED","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2016-12-16","conditions":"Anemia, Sickle Cell, Acute Chest Syndrome","enrollment":198},{"nctId":"NCT04409834","phase":"PHASE4","title":"Prevention of Arteriovenous Thrombotic Events in Critically-Ill COVID-19 Patients Trial","status":"COMPLETED","sponsor":"The TIMI Study Group","startDate":"2020-08-05","conditions":"COVID-19, Venous Thromboembolism, Arterial Thrombosis","enrollment":390},{"nctId":"NCT04406389","phase":"PHASE4","title":"Anticoagulation in Critically Ill Patients With COVID-19 (The IMPACT Trial)","status":"TERMINATED","sponsor":"Weill Medical College of Cornell University","startDate":"2020-10-13","conditions":"COVID-19","enrollment":14},{"nctId":"NCT04373707","phase":"PHASE4","title":"Weight-Adjusted vs Fixed Low Doses of Low Molecular Weight Heparin For Venous Thromboembolism Prevention in COVID-19","status":"COMPLETED","sponsor":"Central Hospital, Nancy, France","startDate":"2020-05-13","conditions":"COVID, Thrombosis, Pulmonary Embolism","enrollment":1000},{"nctId":"NCT04646655","phase":"PHASE3","title":"Enoxaparin at Prophylactic or Therapeutic Doses in COVID-19","status":"COMPLETED","sponsor":"ASST Fatebenefratelli Sacco","startDate":"2020-07-27","conditions":"Covid19, Thrombosis","enrollment":142},{"nctId":"NCT05293132","phase":"PHASE2, PHASE3","title":"Effect of Montelukast Versus Co Enzyme in Sepsis","status":"COMPLETED","sponsor":"Ain Shams University","startDate":"2022-02-01","conditions":"Sepsis","enrollment":90},{"nctId":"NCT04305106","phase":"PHASE3","title":"Bevacizumab in Patients With Severe Covid-19","status":"UNKNOWN","sponsor":"Qilu Hospital of Shandong University","startDate":"2023-01-12","conditions":"COVID-19 Pneumonia","enrollment":588},{"nctId":"NCT05878899","phase":"PHASE3","title":"Postpartum Heparin Against Venous Thromboembolism: a Pilot Randomized Controlled Trial","status":"COMPLETED","sponsor":"University Hospital, Geneva","startDate":"2022-05-03","conditions":"Venous Thromboembolism","enrollment":77},{"nctId":"NCT04542408","phase":"PHASE3","title":"Hamburg Edoxaban for Anticoagulation in COVID-19 Study","status":"COMPLETED","sponsor":"Universitätsklinikum Hamburg-Eppendorf","startDate":"2020-11-12","conditions":"Covid19","enrollment":140},{"nctId":"NCT05224388","phase":"","title":"Evaluating Dose Regimen of Intravenous Unfractionated Heparin and Low Molecular Weight Heparin in Critical Ill Patients Versus Critical Ill COVID-19 Patients Using Anti-Xa Levels.","status":"COMPLETED","sponsor":"University Hospital, Ghent","startDate":"2020-01-01","conditions":"COVID-19, Deep Vein Thrombosis, Anticoagulants and Bleeding Disorders","enrollment":813},{"nctId":"NCT02590601","phase":"PHASE3","title":"Bromocriptine in the Treatment of Peripartum Cardiomyopathy","status":"WITHDRAWN","sponsor":"Montreal Heart Institute","startDate":"2017-01-01","conditions":"Peripartum Cardiomyopathy","enrollment":""},{"nctId":"NCT04512079","phase":"PHASE4","title":"FREEDOM COVID-19 Anticoagulation Strategy","status":"COMPLETED","sponsor":"Valentin Fuster","startDate":"2020-09-08","conditions":"COVID-19, SARS-CoV-2","enrollment":3460},{"nctId":"NCT04655586","phase":"PHASE2, PHASE3","title":"Assessing Safety, Hospitalization and Efficacy of rNAPc2 in COVID-19","status":"COMPLETED","sponsor":"ARCA Biopharma, Inc.","startDate":"2020-12-10","conditions":"Covid19","enrollment":160},{"nctId":"NCT04569279","phase":"PHASE3","title":"Rivaroxaban vs. Warfarin in CVT Treatment","status":"COMPLETED","sponsor":"Damascus University","startDate":"2017-09-01","conditions":"Cerebral Vein Thrombosis","enrollment":71},{"nctId":"NCT02856295","phase":"PHASE4","title":"anti10a Levels in Women Treated With LMWH in the Postpartum Period","status":"COMPLETED","sponsor":"HaEmek Medical Center, Israel","startDate":"2021-11-20","conditions":"Venous Thromboembolism","enrollment":136},{"nctId":"NCT04730856","phase":"NA","title":"Standard vs High Prophylactic Doses or Anticoagulation in Patients With High Risk of Thrombosis Admitted With COVID-19 Pneumonia (PROTHROMCOVID)","status":"COMPLETED","sponsor":"Hospital Universitario Infanta Leonor","startDate":"2021-02-01","conditions":"Covid19, Thrombosis","enrollment":311},{"nctId":"NCT04808882","phase":"PHASE2","title":"ANTIcoagulation in Severe COVID-19 Patients","status":"COMPLETED","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2021-04-14","conditions":"Severe COVID-19 Pneumonia","enrollment":353},{"nctId":"NCT04064489","phase":"NA","title":"Thromboembolic Risk Stratification by TRiP(Cast) Score to Guide Physicians in Preventive Treatment Prescriptions for Patients With Lower Limb Trauma Requiring Brace or castING.","status":"COMPLETED","sponsor":"University Hospital, Angers","startDate":"2020-06-16","conditions":"Lower Limb Trauma, Venous Thromboembolism, Stratification","enrollment":2123},{"nctId":"NCT03395639","phase":"PHASE3","title":"Edoxaban for Prevention of Blood Vessels Being Blocked by Clots (Thrombotic Events) in Children at Risk Because of Cardiac Disease","status":"COMPLETED","sponsor":"Daiichi Sankyo","startDate":"2018-05-15","conditions":"Cardiac Disease","enrollment":168},{"nctId":"NCT04736901","phase":"","title":"Effect of Prophylactic and Therapeutic Anticoagulants in Egyptian Patients With COVID-19","status":"COMPLETED","sponsor":"Ain Shams University","startDate":"2020-12-01","conditions":"Covid19, Corona Virus Infection, Hypercoagulability","enrollment":90},{"nctId":"NCT04770740","phase":"NA","title":"Randomized Controlled Clinical Trial to Investigate Effects of Vitamin K2 in COVID-19","status":"COMPLETED","sponsor":"Canisius-Wilhelmina Hospital","startDate":"2021-02-22","conditions":"Covid19","enrollment":40},{"nctId":"NCT04492254","phase":"PHASE3","title":"Early Prophylactic Low-molecular-weight Heparin (LMWH) in Symptomatic COVID-19 Positive Patients","status":"TERMINATED","sponsor":"Thrombosis Research Institute","startDate":"2020-10-27","conditions":"COVID-19","enrollment":219},{"nctId":"NCT02834559","phase":"PHASE3","title":"Prophylactic Intravitreal 5-Fluorouracil and Heparin to Prevent PVR in High-risk Patients With Retinal Detachment.","status":"COMPLETED","sponsor":"Universitätsklinikum Köln","startDate":"2016-10-27","conditions":"Rhegmatogenous Retinal Detachment, High-risk for Proliferative Vitreoretinopathy (PVR)","enrollment":326},{"nctId":"NCT04623177","phase":"","title":"Thromboprophylaxis for Patients in ICU With COVID-19","status":"COMPLETED","sponsor":"Instituto de Investigacion Sanitaria La Fe","startDate":"2020-03-01","conditions":"Covid19, Anticoagulant Therapy, Thrombosis","enrollment":822},{"nctId":"NCT04394182","phase":"NA","title":"Ultra Low Doses of Therapy With Radiation Applicated to COVID-19","status":"SUSPENDED","sponsor":"Fundacion GenesisCare","startDate":"2020-04-21","conditions":"Pneumonia, Viral, Cytokine Storm","enrollment":15},{"nctId":"NCT04600141","phase":"PHASE3","title":"Clinical Efficacy of Heparin and Tocilizumab in Patients With Severe COVID-19 Infection","status":"COMPLETED","sponsor":"University of Sao Paulo","startDate":"2020-11-10","conditions":"Covid19","enrollment":308},{"nctId":"NCT04305756","phase":"NA","title":"Impact of Prophylactic Low-molecular Weight Heparin Dosing on Clotting Parameters Following Cesarean Delivery","status":"COMPLETED","sponsor":"University of Utah","startDate":"2020-06-12","conditions":"Thromboembolism, Postpartum DVT, Thrombosis","enrollment":146},{"nctId":"NCT04401293","phase":"PHASE3","title":"Full Dose Heparin Vs. Prophylactic Or Intermediate Dose Heparin in High Risk COVID-19 Patients","status":"COMPLETED","sponsor":"Northwell Health","startDate":"2020-04-26","conditions":"Sars-CoV2, COVID","enrollment":257},{"nctId":"NCT05067153","phase":"PHASE4","title":"Thromboprophylaxis in Oesophageal Cancer Patients","status":"UNKNOWN","sponsor":"University of Aarhus","startDate":"2021-05-01","conditions":"Esophageal Neoplasms, Thrombosis, Thromboembolism","enrollment":100},{"nctId":"NCT00571259","phase":"PHASE4","title":"Prophylactic Antimicrobial Catheter Lock","status":"COMPLETED","sponsor":"Satellite Healthcare","startDate":"2003-09","conditions":"Bacteremia","enrollment":303},{"nctId":"NCT04345848","phase":"PHASE3","title":"Preventing COVID-19 Complications With Low- and High-dose Anticoagulation","status":"TERMINATED","sponsor":"University Hospital, Geneva","startDate":"2020-04-28","conditions":"COVID, Sars-CoV2","enrollment":160},{"nctId":"NCT04397289","phase":"PHASE1, PHASE2","title":"Anticoagulation Therapy After Splenectomy in Cirrhosis Patient","status":"COMPLETED","sponsor":"First Affiliated Hospital Xi'an Jiaotong University","startDate":"2018-02-12","conditions":"Liver Cirrhosis, Portal Hypertension, Anticoagulant-induced Bleeding","enrollment":70},{"nctId":"NCT04486508","phase":"PHASE3","title":"Intermediate-dose vs Standard Prophylactic Anticoagulation and Statin vs Placebo in ICU Patients With COVID-19","status":"COMPLETED","sponsor":"Rajaie Cardiovascular Medical and Research Center","startDate":"2020-07-30","conditions":"Covid19","enrollment":600},{"nctId":"NCT04485429","phase":"PHASE3","title":"Efficacy Assessment of Methylprednisolone and Heparin in Patients With COVID-19 Pneumonia","status":"WITHDRAWN","sponsor":"D'Or Institute for Research and Education","startDate":"2020-07-20","conditions":"COVID-19","enrollment":""},{"nctId":"NCT04528888","phase":"PHASE3","title":"Steroids and Unfractionated Heparin in Critically Ill Patients With Pneumonia From COVID-19 Infection","status":"UNKNOWN","sponsor":"Massimo Girardis","startDate":"2020-11-25","conditions":"Covid19, SARS-CoV Infection, Pneumonia, Viral","enrollment":210},{"nctId":"NCT02600260","phase":"NA","title":"Thromboprophylaxis in Pregnant Women in Hospital: A Prospective Clinical Trial","status":"COMPLETED","sponsor":"University of Sao Paulo General Hospital","startDate":"2014-12-01","conditions":"Thrombophilia Associated With Pregnancy, Perioperative/Postoperative Complications, Venous Thrombosis","enrollment":7212},{"nctId":"NCT04829552","phase":"","title":"Prophylactic Versus Therapeutic Dose Anticoagulation In COVID-19 Infection at the Time of Admission To Critical Care Units","status":"COMPLETED","sponsor":"Corewell Health East","startDate":"2020-03-10","conditions":"Covid19","enrollment":704},{"nctId":"NCT00362947","phase":"PHASE3","title":"Different Doses and Duration of Low Molecular Weight Heparin (Parnaparin)in Superficial Vein Thrombosis","status":"COMPLETED","sponsor":"IRCCS Azienda Ospedaliero-Universitaria di Bologna","startDate":"2006-08","conditions":"Thrombophlebitis","enrollment":664},{"nctId":"NCT04671160","phase":"","title":"Impact of Continuous Veno-venous Hemodiafiltration on Efficacy of Administration of Prophylactic Doses of Enoxaparin or Fondaparinux in Critically Ill Patients.","status":"UNKNOWN","sponsor":"Medical University of Gdansk","startDate":"2021-01-04","conditions":"Assessment of Activity of Anti-Xa Factor in Patients Treated With Continuous Veno-venous Hemodiafiltration Receiving Anticoagulant Prophylaxis","enrollment":80},{"nctId":"NCT04507282","phase":"","title":"Eosinophil and Anticoagulation in COVID-19 Patients","status":"COMPLETED","sponsor":"Bursa Postgraduate Hospital","startDate":"2020-05-15","conditions":"COVID-19","enrollment":80},{"nctId":"NCT04508439","phase":"NA","title":"Effect of the Use of Anticoagulant Therapy During Hospitalization and Discharge in Patients With COVID-19 Infection","status":"UNKNOWN","sponsor":"Hospital Regional de Alta especialidad de Ixtapaluca","startDate":"2020-06-20","conditions":"Covid19, Pneumonia, Coagulation Disorder","enrollment":130},{"nctId":"NCT04361643","phase":"PHASE4","title":"Low-dose Lenalidomide for Non-severe COVID-19 Treatment Trial","status":"UNKNOWN","sponsor":"Hospital Universitario Getafe","startDate":"2020-10-27","conditions":"COVID-19","enrollment":120},{"nctId":"NCT03683212","phase":"NA","title":"Early and Comprehensive Care Bundle in Elderly for Acute Heart Failure: a Stepped Wedge Cluster Randomized Trial","status":"COMPLETED","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2018-12-10","conditions":"Acute Heart Failure","enrollment":503},{"nctId":"NCT03528967","phase":"PHASE4","title":"Enoxaparin in the Prevention of Placental Insufficiency in Pregnant Women","status":"COMPLETED","sponsor":"Les Laboratoires des Médicaments Stériles","startDate":"2013-10-23","conditions":"Placental Insufficiency, Enoxaparin","enrollment":89},{"nctId":"NCT04256525","phase":"PHASE4","title":"Prophylactic Anticoagulation for Catheter-related Thrombosis","status":"UNKNOWN","sponsor":"Second Affiliated Hospital, School of Medicine, Zhejiang University","startDate":"2020-05-01","conditions":"Venous Thrombosis Due to Central Venous Access Device (Disorder), Prophylactic Anticoagulation, Patients With Tumor","enrollment":1640},{"nctId":"NCT04412746","phase":"","title":"Covid-19 and Diabetes in West of Algeria","status":"UNKNOWN","sponsor":"Laboratoire De Recherche Sur Le Diabete, Université de Tlemcen","startDate":"2020-04-01","conditions":"Coronavirus Infections, Diabetes Mellitus, Prevalence","enrollment":100},{"nctId":"NCT04344756","phase":"PHASE2","title":"Trial Evaluating Efficacy and Safety of Anticoagulation in Patients With COVID-19 Infection, Nested in the Corimmuno-19 Cohort","status":"UNKNOWN","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2020-04-20","conditions":"COVID19 Pneumonia","enrollment":808},{"nctId":"NCT03963336","phase":"EARLY_PHASE1","title":"Quantitative D-dimer Level and Anticoagulant Therapy in Idiopathic Intracranial Hypertension","status":"COMPLETED","sponsor":"Fayoum University","startDate":"2017-07-22","conditions":"Idiopathic Intracranial Hypertension","enrollment":48},{"nctId":"NCT03805672","phase":"PHASE4","title":"Below Knee DVT Study","status":"TERMINATED","sponsor":"Oregon Health and Science University","startDate":"2014-09","conditions":"Deep Vein Thrombosis (DVT), Blood Clots","enrollment":4},{"nctId":"NCT02719418","phase":"","title":"Study of the Bioaccumulation of Tinzaparin in Renally Impaired Patients When Given at Prophylactic Doses","status":"COMPLETED","sponsor":"Maisonneuve-Rosemont Hospital","startDate":"2016-02-01","conditions":"Renal Insufficiency, Chronic, Deep Venous Thrombosis, Protection Against","enrollment":28},{"nctId":"NCT03601338","phase":"EARLY_PHASE1","title":"Low Molecular Weight Heparin in Pregnancies With Unexplained Stillbirths","status":"COMPLETED","sponsor":"Hawler Medical University","startDate":"2015-08-01","conditions":"Unexplained Stillbirth","enrollment":140},{"nctId":"NCT02334007","phase":"PHASE1, PHASE2","title":"Extended Low-Molecular Weight Heparin VTE Prophylaxis in Thoracic Surgery","status":"COMPLETED","sponsor":"McMaster University","startDate":"2015-09","conditions":"Venous Thromboembolism, Lung Neoplasms, Pulmonary Embolism","enrollment":102},{"nctId":"NCT02036255","phase":"PHASE3","title":"Prevention of Dialysis Catheter Malfunction With Prophylactic Use of a Taurolidine Containing Urokinase","status":"COMPLETED","sponsor":"Universitair Ziekenhuis Brussel","startDate":"2015-05","conditions":"Patency, Infection","enrollment":68},{"nctId":"NCT00585182","phase":"PHASE4","title":"Study to Evaluate Weight-based Enoxaparin Dosing in Obese Medical Patients at Risk for DVT","status":"COMPLETED","sponsor":"University of Utah","startDate":"2007-01","conditions":"Obesity, Venous Thrombosis, Anticoagulants","enrollment":28},{"nctId":"NCT02271295","phase":"PHASE3","title":"Impact on Morbidity and Mortality of Prophylactic Dosing of Low Molecular Heparin in Child-Pugh B Cirrhotic Patients","status":"SUSPENDED","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2015-07-27","conditions":"Cirrhosis","enrollment":16},{"nctId":"NCT00225108","phase":"PHASE2, PHASE3","title":"The STOP CLOT Pilot Study: Study of Low Molecular Weight Heparin in High Risk Cesarean Section","status":"COMPLETED","sponsor":"Ottawa Hospital Research Institute","startDate":"2002-07","conditions":"Deep Vein Thrombosis","enrollment":30},{"nctId":"NCT02227329","phase":"PHASE1, PHASE2","title":"Prophylactic Ethanol Lock Therapy (ELT) in Patients on Home Parenteral Nutrition","status":"TERMINATED","sponsor":"Mayo Clinic","startDate":"2014-07","conditions":"Catheter-related Bloodstream Infection (CRBSI) Nos, Bloodstream Infection Due to Central Venous Catheter, Bloodstream Infection Due to Hickman Catheter","enrollment":39},{"nctId":"NCT01518465","phase":"PHASE2","title":"Dalteparin, Lenalidomide, and Low-Dose Dexamethasone in Treating Patients With Previously Untreated Multiple Myeloma","status":"TERMINATED","sponsor":"University of Southern California","startDate":"2012-01-09","conditions":"Stage I Multiple Myeloma, Stage II Multiple Myeloma, Stage III Multiple Myeloma","enrollment":13},{"nctId":"NCT01149304","phase":"PHASE2","title":"Preventive Effect of Enoxaparin, Pentoxifylline and Ursodeoxycholic Acid to Radiation Induced Liver Toxicity","status":"COMPLETED","sponsor":"University of Magdeburg","startDate":"2009-06","conditions":"Colorectal Cancer, Liver Metastases, Irradiation Damage","enrollment":22},{"nctId":"NCT01941602","phase":"","title":"A Comparative Study of Prophylactic Anticoagulation in Meningioma Surgery","status":"COMPLETED","sponsor":"St. Olavs Hospital","startDate":"2013-08","conditions":"Meningioma","enrollment":979},{"nctId":"NCT03277001","phase":"NA","title":"Study of Prophylactic Effect of Rivaroxaban on Venous Thromboembolism in AECOPD","status":"UNKNOWN","sponsor":"Huashan Hospital","startDate":"2017-10-01","conditions":"Acute Exacerbation Copd, Venous Thromboembolism","enrollment":438},{"nctId":"NCT01274637","phase":"PHASE3","title":"PROSPER: PostpaRtum PrOphylaxiS for PE Randomized Control Trial Pilot","status":"COMPLETED","sponsor":"Ottawa Hospital Research Institute","startDate":"2011-03","conditions":"Venous Thromboembolism, Postpartum","enrollment":62},{"nctId":"NCT01308528","phase":"PHASE3","title":"Prophylactic Use of Sodium Enoxaparin for Venous Thromboembolism in High-Risk Abdominal Surgery","status":"COMPLETED","sponsor":"Cristália Produtos Químicos Farmacêuticos Ltda.","startDate":"2015-02","conditions":"Venous Thromboembolism","enrollment":243},{"nctId":"NCT03157843","phase":"","title":"Rate of Venous Thrombosis in Acutely Ill Patients Hospitalized in Internal Medicine Wards","status":"UNKNOWN","sponsor":"University of Roma La Sapienza","startDate":"2015-02","conditions":"Venous Thromboembolism, Deep Venous Thrombosis","enrollment":1000},{"nctId":"NCT02260414","phase":"PHASE2","title":"Effects of Anticoagulant Preventive Injection in Patients With Blood Cancer","status":"COMPLETED","sponsor":"Centre Hospitalier Universitaire de Saint Etienne","startDate":"2015-04-14","conditions":"Lymphoma, Multiple Myeloma","enrollment":19},{"nctId":"NCT01448746","phase":"PHASE3","title":"Optimal Prophylactic Method of Venous Thromboembolism (VTE)","status":"UNKNOWN","sponsor":"The Catholic University of Korea","startDate":"2011-10","conditions":"Venous Thromboembolism","enrollment":682},{"nctId":"NCT00878826","phase":"PHASE2, PHASE3","title":"Prophylactic Enoxaparin Dosing for Prevention of Venous Thromboembolism in Pregnancy.","status":"COMPLETED","sponsor":"Stanford University","startDate":"2009-05","conditions":"Venous Thrombosis","enrollment":11},{"nctId":"NCT02991950","phase":"PHASE3","title":"Weight Adjusted Low Molecular Weight Heparin in Recurrent Implantation Failure: a Randomized Open Labeled Trial","status":"TERMINATED","sponsor":"Istituto Clinico Humanitas","startDate":"2011-07","conditions":"Infertility, Low Molecular Weight Heparin","enrollment":271},{"nctId":"NCT01542762","phase":"NA","title":"Pot-Cast: Thrombosis Prophylaxis During Plaster Cast Lower Leg Immobilisation","status":"COMPLETED","sponsor":"Suzanne C. Cannegieter, MD PhD","startDate":"2012-03","conditions":"Deep Venous Thrombosis, Pulmonary Embolism","enrollment":1500},{"nctId":"NCT01542723","phase":"NA","title":"Pot-Kast: Thrombosis Prophylaxis After Knee Arthroscopy","status":"COMPLETED","sponsor":"Suzanne C. Cannegieter, MD PhD","startDate":"2012-05","conditions":"Deep Venous Thrombosis, Pulmonary Embolism","enrollment":1500}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":220,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["enoxaparin","dalteparin","Tinzaparin","Fondparinux","Heparin"],"phase":"marketed","status":"active","brandName":"prophylactic heparin","genericName":"prophylactic heparin","companyName":"Matthew Neal MD","companyId":"matthew-neal-md","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Prophylactic heparin is used to study conditions such as anemia, sickle cell, acute chest syndrome, and acute exacerbation of COPD. It works by activating antithrombin-III, a protein that helps regulate blood clotting, through its oligosaccharide modality.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":1,"withResults":1},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}